Accessibility navigation

MALDI mass spectrometry in prostate cancer biomarker discovery

Flatley, B., Malone, P. and Cramer, R. ORCID: (2014) MALDI mass spectrometry in prostate cancer biomarker discovery. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1844 (5). pp. 940-949. ISSN 1570-9639

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1016/j.bbapap.2013.06.015


Matrix-assisted laser desorption/ionisation (MALDI) mass spectrometry (MS) is a highly versatile and sensitive analytical technique, which is known for its soft ionisation of biomolecules such as peptides and proteins. Generally, MALDI MS analysis requires little sample preparation, and in some cases like MS profiling it can be automated through the use of robotic liquid-handling systems. For more than a decade now, MALDI MS has been extensively utilised in the search for biomarkers that could aid clinicians in diagnosis, prognosis, and treatment decision making. This review examines the various MALDI-based MS techniques like MS imaging, MS profiling and proteomics in-depth analysis where MALDI MS follows fractionation and separation methods such as gel electrophoresis, and how these have contributed to prostate cancer biomarker research. This article is part of a Special Issue entitled: Biomarkers: A Proteomic Challenge.

Item Type:Article
Divisions:Interdisciplinary centres and themes > Chemical Analysis Facility (CAF)
Life Sciences > School of Chemistry, Food and Pharmacy > Department of Chemistry
ID Code:36427
Uncontrolled Keywords:Prostate cancer; Biomarkers; MALDI MS; MS profiling; MS imaging

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation